Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Trillium Therapeutics Inc (TRIL.TO)

Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Trillium Therapeutics Inc 100 CambridgePark Drive Suite 510 Cambridge MA 02140 USA

https://www.trilliumtherapeutics.com P: 416-595-0627

Description:

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

Key Statistics

Overview:

Market Capitalization, $K 2,426,437
Shares Outstanding, K 104,995
Annual Sales, $ 148 K
Annual Net Income, $ -59,346 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -19,316 K
60-Month Beta 1.40
% of Institutional Shareholders 30.68%

Growth:

1-Year Return 1.66%
3-Year Return 540.93%
5-Year Return 110.37%

Per-Share Information:

Most Recent Earnings -0.18 on 11/12/21
Next Earnings Date 11/15/21
Earnings Per Share ttm -0.51
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -133.99%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 11/20/14

TRIL.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -28.51%
Return-on-Assets % -19.85%
Profit Margin % -40,098.65%
Debt/Equity 0.00
Price/Sales 44,312.87
Price/Book 8.52
Book Value/Share 2.71
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar